By Victor E. Long, Esq.
Yesterday, the Food and Drug Administration recommended that children shouldn’t stop taking drugs that treat attention deficit hyperactivity disorder, or ADHD, despite a study showing the stimulants may be associated with sudden death. Stimulants used to treat attention deficit hyperactivity disorder could increase the risk of sudden death in children who have no underlying heart conditions.
Popular stimulant medications used to treat ADHD in children and teens include such drugs as Shire’s Adderall and Novartis’ Ritalin. The drugs have previously been approved as both safe and effective in the treatment of ADHD in children by the FDA, and remain so despite the recent study.
For more information on drug related injuries, read about the decision of the U.S. Supreme Court on suing drugmakers over injuries from medicines approved by the government.